Skip to main content
Clinical Trials/NCT03616522
NCT03616522
Completed
Not Applicable

A Prospective Study of Electronic Symptom Reporting Via Mobile Phone Among Patients With Advanced Non-Small Cell Lung Cancer

Abramson Cancer Center at Penn Medicine1 site in 1 country25 target enrollmentMay 21, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Non-small Cell Lung Cancer
Sponsor
Abramson Cancer Center at Penn Medicine
Enrollment
25
Locations
1
Primary Endpoint
Number of subjects who will adhere to the mobile phone-based intervention
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Symptoms are common among patients with advanced malignancy undergoing treatment, and yet often go unrecognized by treatment providers. In addition to contributing to morbidity, poorly controlled symptoms drive emergency room utilization and hospital admission in this population, representing significant cost to patients, families, and the health care system. Systematic collection of patient-reported outcomes (PROs) has been proposed as a way to arm providers with the information necessary to intervene early, intensify symptom management, and improve symptom control. Recent research suggests that a standardized, web-based program of weekly patient-reported symptom monitoring leads to improved health-related quality of life and reduced acute care utilization; it may also prolong overall survival. Despite mounting evidence supporting its use among oncology patients, systematic PRO collection is lacking at most cancer centers, and optimal models for collection of PROs are poorly understood. The objective of this study is to evaluate prospectively the feasibility of a novel mobile phone-based intervention of weekly symptom reporting, among patients undergoing treatment for advanced non-small cell lung cancer.

Registry
clinicaltrials.gov
Start Date
May 21, 2018
End Date
February 18, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult patient (age ≥ 18 years) with advanced (metastatic) non-small cell lung cancer, initiating a new line of palliative-intent treatment at Abramson Cancer Center
  • Ability to read and respond to questions in English
  • Ability to provide informed consent to participate in the study
  • Access to a smart phone capable of SMS-text messaging and internet access

Exclusion Criteria

  • Inability to read and respond to questions in English
  • Inability or unwillingness to provide informed consent to participate in the study
  • Inability to engage with SMS-text based platform
  • Current enrollment in a clinical trial

Outcomes

Primary Outcomes

Number of subjects who will adhere to the mobile phone-based intervention

Time Frame: 3 months

evaluate subjects to study-level adherence of a mobile phone-based intervention for automated PRO collection

Study Sites (1)

Loading locations...

Similar Trials